Tag: https://www.bio.org/events/bio-international-convention

Oct 18
BIO Chair Ted Love's Interview with Patrice Sanders of Fox News on the Future of Sickle Cell Disease

The William E. Proudford Sickle Cell Fund’s 2023 Distinguished Service Award recipient Ted Love, BIO Chair and Former CEO of Global Blood Therapeutics (GBT), talks about the future of Sickle Cell Disease with Patrice Sanders of Fox News. You can view the full interview here: https://www.youtube.com/watch?v=PoOIZ0PhsQQ source

Oct 17
Fireside Chat with Governor Wes Moore on Maryland’s Life Sciences Industry

Fireside Chat on Life Science Industry in Maryland with Governor Moore and Rachel King, CEO of BIO Moderated by Dr. Bruce Jarrell, President of UMB. This event is intended to highlight the breadth and impact of Maryland’s bioscience community and to showcase the transformation of Maryland into a world-class center of biomedical innovation. source

Oct 16
BIO Policy Pulse: BIO CEO Meets Maryland Governor to Highlight State’s Relationship with Biotech

BIO CEO Rachel King and Governor Wes Moore joined life sciences industry leaders at the University of Maryland (UM) BioPark … source

Oct 06
Rachel Diamant, Co-Founder, Emendo Biotherapeutics

Rachel Diamant, Co-Founder of Emendo Biotherapeutics, talks about her company’s new generation of gene editing technology … source

Oct 05
House Oversight Committee Hearing on the Inflation Reduction Act (IRA)

Rep. Lisa McClain, Chair of the House Subcommittee on Health Care and Financial Services, and Joel White, President of the Council for Affordable Health Coverage, discuss the negative impact of the IRA on drug development, at the House Oversight Committee’s hearing, “The Inflation Reduction Act: A Year in Review” on September 14, 2023. source

Oct 04
BIO's Policy Pulse: Preview of BIO Vice Chair John Crowley Testimony on Price Controls

A preview of this week’s House Oversight and Investigations Subcommittee Hearing on the Inflation Reduction Act: “At What Cost: Oversight of How the IRA’s Price Setting Scheme Means Fewer Cures for Patients.” Aiken Hackett, BIO’s VP of Federal Government Relations, previews the hearing and tells us what to expect. (September 20, 2023) The House hearing […]

Oct 03
BIO's Policy Pulse: BIO Vice Chair John Crowley to Congress: IRA Reduces Access to Innovative Drugs

John Crowley, CEO of Amicus Therapeutics and Vice Chair of the Board of the Biotechnology Innovation Organization (BIO), told Congress that drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, as he testified before the House Energy & Commerce Oversight and Investigations Subcommittee on Sept. 20, 2023. Bio.News: https://bio.news/latest-news/bio-board-vice-chair-crowley-tells-congress-ira-reduces-access-to-innovative-drugs/ […]